No Data
No Data
Express News | Kintara Therapeutics Expands REM-001 Clinical Study To Include Patients On Pembrolizumab
Kintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on Pembrolizumab
HEAR, SOUN and WW Are Among After Hour Movers
What's Going On With Kintara Therapeutics Stock?
Kintara Therapeutics, Inc. (NASDAQ:KTRA) shares are volatile Wednesday after the company announced it is seeking withdrawal of its registration statement for a public offering of securities.The Detail
HRTX, LUNA and ARQ Among Mid-day Movers
Express News | Kintara Therapeutics Shares Are Trading Higher After the Company Announced That It Is Seeking Withdrawal of the Registration Statement and Does Not Intend to Pursue the Contemplated Public Offering of Securities
loading...
No Data